Process simulation as a decision support tool for biopharmaceutical process development in a South African context
In 2010 the incidence of neo-natal Group B Streptococcus (GBS) disease in South Africa was 3 per 1000 live births, more than twice the global average of 1.21 per 1000 live births. A recent life cycle impact assessment showed that a new vaccine against GBS disease in South Africa could have a potenti...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Dissertation |
| Language: | English |
| Published: |
Faculty of Engineering and the Built Environment
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11427/32553 |